Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / B•••••

L•••••• C•••••• P••••••• Invests in B••••• To Life to Back the Next Chapter in Organ Preservation

Platform acquisitionannouncedannounced Aug 12, 2026Fact
What happened
Target
B•••••
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
unknown
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
7 named
Buy side
  • L•••••• C•••••• P•••••••Sponsorconfirmed
    “L•••••• C•••••• P••••••• Invests in B••••• To Life to Back the Next Chapter in Organ Preservation | published on L•••••• C•••••• P•••••••'s own news page lauxera.com”
Financing side
  • S••••• C•••••• C••••• O••••••••• F•••Lenderconfirmed
    “The equity financing was led by new investor S••••• Capital, along with L•••••• C•••••• P••••••• and participation by B••••• to Life directors, officers, and employees; the debt financing was provided by S••••• C•••••• C••••• O••••••••• F•••.”
Advisory side
  • L•••• • B•••••• L••Legal adviserconfirmed
    “Morgan, L•••• • B•••••• L•• acted as legal counsel for B••••• to Life in connection with the transaction.”
  • U•• I••••••••• B•••Placement agentconfirmed
    “U•• I••••••••• B••• acted as exclusive financial advisor and placement agent to B••••• to Life in connection with the transaction.”
  • U•• I••••••••• B•••Sell-side adviserconfirmed
    “U•• I••••••••• B••• acted as exclusive financial advisor and placement agent to B••••• to Life in connection with the transaction.”
Side not stated
  • D•• W•••••Managementconfirmed
    ““B••••• to Life is committed to improving transplant medicine through science-based solutions that bring more organs to more patients,” said D•• W•••••, CEO and President of B••••• to Life™ Ltd. “This financing marks an important milestone for B••••• to Life and reflects the confidence our investors”
  • B•••••Targetconfirmed
    “L•••••• C•••••• P••••••• Invests in B••••• To Life to Back the Next Chapter in Organ Preservation”
Evidence
“L•••••• C•••••• P••••••• Invests in B••••• To Life to Back the Next Chapter in Organ Preservation”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 17, 2026
L•••••• C•••••• P••••••• Invests in B••••• To Life to Back the Next Chapter in Organ Prese | Private Equity Intelligence | DFX